Dr. Sarah Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung Cancer

March 29, 2016
Sarah Goldberg, MD

Sarah Goldberg, MD, MPH, assistant professor of Medicine and Medical Oncology, Yale Cancer Center, discusses coming trials looking at immunotherapy beyond the second-line setting in non-small cell lung cancer (NSCLC).

Sarah Goldberg, MD, MPH, assistant professor of Medicine and Medical Oncology, Yale Cancer Center, discusses coming trials looking at immunotherapy beyond the second-line setting in non-small cell lung cancer (NSCLC). Goldberg says the most exciting part about these trial is finding out if combination immunotherapy treatment regimens could work better than single-agent regimens.